PSAP and intervertebral disk degenerative disorder: This finding is supported by previous research showing that glycosylation can modulate receptor‐ligand interactions and downstream signaling events.[53, 54] Our results suggest that the glycosylation status of PSAP is a critical determinant of its biological activity, and manipulating this post‐translational modification could have therapeutic potential in IDD.